Drug intelligence / Profile preview

nifurpirinol

Development stage
Unknown
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral, Immersion
01

Overview

Nifurpirinol is a synthetic nitrofuran derivative and small molecule antibiotic primarily used in veterinary medicine, especially for the treatment of bacterial infections in fish. It acts as a prodrug that requires activation by bacterial nitroreductase enzymes, leading to the formation of cytotoxic metabolites that cause cell death. Its mechanism of action involves inhibition of nucleic acid (particularly DNA) synthesis and interference with key bacterial enzyme systems involved in glucose and pyruvate metabolism, resulting in broad-spectrum antibacterial activity against various Gram-negative pathogens such as Vibrio anguillarum and Aeromonas species. Nifurpirinol is notable for its high potency at low concentrations compared to other nitrofuran antibiotics. While mainly used in aquaculture, it has also been explored as a research tool for targeted cell ablation using engineered nitroreductase-expressing models[1][4][5][6][7][8].

Brand names
Furanace
Other names
FurpyrinolNifurpirinolum
02

Targets

NTR (Bacterial nitroreductase)

Beyond the preview

Go deeper on nifurpirinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nifurpirinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call